Taken together, these results demonstrate that Cirbp silencing in vivo sensitizes NPC xenograft tumor to local hyperthermia treatment, and thus substantially boosts anti-tumor killing effects of hyperthermia against NPC cells and cancer stem-like cells in vivo. The gene discussed is CIRBP; the disease is neoplasm.